Page last updated: 2024-10-29

ketoconazole and Diseases of Pharynx

ketoconazole has been researched along with Diseases of Pharynx in 12 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Research Excerpts

ExcerptRelevanceReference
"Itraconazole and fluconazole are two relatively new anti-fungal agents which are being used successfully in the treatment of oropharyngeal candidiasis."8.78Itraconazole and fluconazole in oropharyngeal candidiasis. ( Arendorf, TM; van der Bijl, P, 1993)
"In a randomised, double-blind study the efficacy and toxicity of oral fluconazole 50 mg daily and ketoconazole 200 mg daily were compared for the treatment of oropharyngeal candidiasis in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC)."5.06Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. ( Clumeck, N; De Wit, S; Goossens, H; Weerts, D, 1989)
"A systematic review of randomized clinical trials published between 1966 and April 2000 was undertaken to determine the strength of evidence for the effectiveness of antifungal drugs (nystatin, clotrimazole, amphotericin B, fluconazole, ketoconazole, and itraconazole) to prevent and treat oral candidiasis in human immunodeficiency virus-positive patients."4.81A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients. ( Bonito, AJ; Patton, LL; Shugars, DA, 2001)
"Itraconazole and fluconazole are two relatively new anti-fungal agents which are being used successfully in the treatment of oropharyngeal candidiasis."4.78Itraconazole and fluconazole in oropharyngeal candidiasis. ( Arendorf, TM; van der Bijl, P, 1993)
" Twenty-four subjects received oral fluconazole in a dosage of 3 mg/kg/day and 22 subjects received oral ketoconazole in a dosage of 7 mg/kg/day."2.67Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group. ( Hernández-Sampelayo, T, 1994)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19905 (41.67)18.7374
1990's3 (25.00)18.2507
2000's4 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Quintiliani, R1
Owens, NJ1
Quercia, RA1
Klimek, JJ1
Nightingale, CH1
Force, RW1
Nahata, MC1
Hernández-Sampelayo, T1
van der Bijl, P1
Arendorf, TM1
Walmsley, S1
King, S1
McGeer, A1
Ye, Y1
Richardson, S1
Samaranayake, YH1
Samaranayake, LP2
Tsang, PC1
Wong, KH1
Yeung, KW1
Patton, LL1
Bonito, AJ1
Shugars, DA1
Anil, S1
Ellepola, AN1
De Wit, S1
Weerts, D1
Goossens, H1
Clumeck, N1
Thamlikitkul, V1
Danpakdi, K1
Visuthisakchai, S1
Kulpreedarat, T1
Berkowitz, RJ1
Hughes, C1
Rudnick, M1
Gordon, EM1
Strandjord, S1
Cheung, NK1
Warkentin, P1
Coccia, PF1

Reviews

2 reviews available for ketoconazole and Diseases of Pharynx

ArticleYear
Itraconazole and fluconazole in oropharyngeal candidiasis.
    Annals of dentistry, 1993,Winter, Volume: 52, Issue:2

    Topics: Antifungal Agents; Candidiasis; Candidiasis, Oral; Fluconazole; Humans; Itraconazole; Ketoconazole;

1993
A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2001, Volume: 92, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis,

2001

Trials

5 trials available for ketoconazole and Diseases of Pharynx

ArticleYear
Treatment and prevention of oropharyngeal candidiasis.
    The American journal of medicine, 1984, Oct-30, Volume: 77, Issue:4D

    Topics: Adolescent; Adult; Aged; Aspergillosis; Candidiasis; Child; Child, Preschool; Clinical Trials as Top

1984
Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis.
    The Annals of pharmacotherapy, 1995, Volume: 29, Issue:1

    Topics: Administration, Oral; Adult; Candida albicans; Candidiasis; Chromatography, High Pressure Liquid; Cr

1995
Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1994, Volume: 13, Issue:4

    Topics: Adolescent; Age Factors; AIDS-Related Opportunistic Infections; Candida; Candidiasis, Oral; Child; C

1994
Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS.
    Lancet (London, England), 1989, Apr-08, Volume: 1, Issue:8641

    Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Complex; Candidi

1989
Randomized controlled trial of clotrimazole troche and ketoconazole for oropharyngeal candidiasis.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1988, Volume: 71, Issue:12

    Topics: Administration, Oral; Adolescent; Adult; Aged; Candidiasis; Clinical Trials as Topic; Clotrimazole;

1988

Other Studies

5 other studies available for ketoconazole and Diseases of Pharynx

ArticleYear
Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Jun-01, Volume: 32, Issue:11

    Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Child; Dru

2001
Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2001, Volume: 30, Issue:6

    Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Analysis of Variance; Antifungal Agent

2001
Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2001, Volume: 30, Issue:8

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candida albicans;

2001
Fluconazole versus ketoconazole in oropharyngeal candidiasis in AIDS.
    Lancet (London, England), 1989, May-20, Volume: 1, Issue:8647

    Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Female; Fluconazole; Humans; Ketoconazole; Ma

1989
Oropharyngeal Candida prophylaxis in pediatric bone marrow transplant patients.
    The American journal of pediatric hematology/oncology, 1985,Spring, Volume: 7, Issue:1

    Topics: Adolescent; Anemia, Aplastic; Bone Marrow Transplantation; Burkitt Lymphoma; Candidiasis; Child; Chi

1985